{
    "organizations": [],
    "uuid": "d266c844b13d907eb80e8764b213f003d8ac44c5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-auris-medical-announces-further-re/brief-auris-medical-announces-further-results-from-healos-phase-3-trial-idUSFWN1OZ0PY",
    "ord_in_thread": 0,
    "title": "BRIEF-Auris Medical Announces Further Results From Healos Phase 3 Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 5:44 PM / Updated 7 minutes ago BRIEF-Auris Medical Announces Further Results From Healos Phase 3 Trial Reuters Staff 1 Min Read \nJan 4 (Reuters) - Auris Medical Holding Ag: \n* AURIS MEDICAL HOLDING AG SAYS ANNOUNCED FURTHER CLINICAL RESULTS FROM THE HEALOS PHASE 3 CLINICAL TRIAL, PROVIDES UPDATE ON AM-111 DEVELOPMENT PROGRAM \n* AURIS MEDICAL HOLDING AG SAYS AM-111 TREATED PATIENTS HAD A LOWER INCIDENCE OF NO HEARING IMPROVEMENT- SEC FILING \n* AURIS MEDICAL HOLDING SAYS POST-HOC ANALYSES OF TOP-LINE DATA REVEALED CLINICALLY AND STATISTICALLY SIGNIFICANT HEARING IMPROVEMENT WITH AM-111 \n* AURIS MEDICAL HOLDING SAYS PLANS TO DISCUSS ACCUMULATED SAFETY AND EFFICACY DATA AND REGULATORY PATHWAY WITH FDA AND EMA IN Q2 OF 2018. Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T19:43:00.000+02:00",
    "crawled": "2018-01-04T20:06:20.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "medical",
        "announces",
        "result",
        "healos",
        "phase",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "auris",
        "medical",
        "holding",
        "ag",
        "auris",
        "medical",
        "holding",
        "ag",
        "say",
        "announced",
        "clinical",
        "result",
        "healos",
        "phase",
        "clinical",
        "trial",
        "provides",
        "update",
        "development",
        "program",
        "auris",
        "medical",
        "holding",
        "ag",
        "say",
        "treated",
        "patient",
        "lower",
        "incidence",
        "hearing",
        "sec",
        "filing",
        "auris",
        "medical",
        "holding",
        "say",
        "analysis",
        "data",
        "revealed",
        "clinically",
        "statistically",
        "significant",
        "hearing",
        "improvement",
        "auris",
        "medical",
        "holding",
        "say",
        "plan",
        "discus",
        "accumulated",
        "safety",
        "efficacy",
        "data",
        "regulatory",
        "pathway",
        "fda",
        "ema",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}